Crispr gene-editing ‘revolution’ treats internal organ for first time Crispr基因編輯「革命」首次被用於治療內臟
US start-up co-founded by Nobel laureate marks breakthrough over therapies restricted to external cells 美國新創企業Intellia的早期試驗數據標誌着Crispr療法取得突破，表明科學家克服了先前僅能將該技術用於編輯體外細胞的侷限。